ESPR - Esperion Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
Cash flows from operating activities
Net Income
-76,792
Depreciation & amortization
267
Deferred income taxes
-
Stock based compensation
25,523
Change in working capital
22,746
Accounts receivable
-
Inventory
-
Accounts Payable
5,634
Other working capital
-29,111
Other non-cash items
-
Net cash provided by operating activites
-28,537
Cash flows from investing activities
Investments in property, plant and equipment
-
Acquisitions, net
-
Purchases of investments
-4,941
Sales/Maturities of investments
156,523
Other investing activites
-
Net cash used for investing activites
151,008
Cash flows from financing activities
Debt repayment
-153
Common stock issued
-
Common stock repurchased
-
Dividends Paid
-
Other financing activites
-
Net cash used privided by (used for) financing activities
128,421
Net change in cash
250,892
Cash at beginning of period
24,380
Cash at end of period
275,272
Free Cash Flow
Operating Cash Flow
-28,537
Capital Expenditure
-
Free Cash Flow
-29,111